Clinical trial
Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
NCT07087873 is registered in ClinicalTrials.gov with Xuanwu Hospital, Beijing as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
- Lead sponsor
- Xuanwu Hospital, Beijing
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 30, 2025
- Completion date
- October 31, 2027
- Enrollment
- 128 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute disseminated encephalomyelitis, idiopathic inflammatory demyelinating disorders of the central nervous system, ms (multiple sclerosis), nmosd, transcranial alternating current stimulation